HK2 and breast carcinoma: In particular, hsa-let-7b-5p has been shown to inhibit aerobic glycolysis and metastasis in breast cancer by repressing hexokinase 2, indicating its central role in metabolic reprogramming and tumor suppression (PMID: 37019900).